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Abstract 
Proteins, participating in a myriad of biological function, are at the core of all cellular activities occurring 
within living organisms. Therapeutic proteins, hence constitute a major part of the pharmaceutical 
industry.  The glycoprotein hormones follicle stimulating hormone (FSH), luteinizing hormone (LH), 
thyroid stimulating hormone (TSH) and human chorionic gonadotropin (CG) regulate various 
reproductive and metabolic functions in humans and hence have high therapeutic potentials. The 
increasing demand of recombinant proteins for therapeutic uses drives the development of better 
expression systems.   
The methylotrophic yeast Pichia pastoris, has been termed as an industrial workhorse for heterologous 
protein expression. However, the N-glycosyalation in yeast is of the high mannose type, resulting in a 
reduced serum half-life of the recombinant proteins. In the current work, we have re-engineered the 
Pichia N-glycosylation pathway to mimic the human type of N-glycosylation. Towards this end, we 
abolished the yeast native N-glycosylation and introduced enzymes from various eukaryotic sources into 
the system. These modifications resulted in the conversion of the yeast Man9-20GlcNAc2 glycan structure 
to a more human like GlcNAc2Man3GlcNAc2 form on over 70 % of the heterologous expressed proteins.  
In order to demonstrate the application of these strains as efficient protein expression hosts, the 
glycoengineerd Pichia was used for large scale expression of the glycoprotein hormones, hCG and FSH. 
The purified recombinant hormones were found to have binding affinities and structure similar to that of 
the natural hormones. These recombinant hormones were also able to elicit over two fold responses in 
animal models compared to buffer controls and the activity was comparable to the natural couterparts. 
Thus, we report the generation of a glycoengineered Pichia pastoris, which can be considered as a serious 
contender for the expression of glycosylated proteins of therapeutic importance.   
